一种雷帕霉素与长春新碱的药物组合
- 专利权人:
- 杭州泛普生物科技有限公司
- 发明人:
- 陈希
- 申请号:
- CN201510366245.0
- 公开号:
- CN105030774A
- 申请日:
- 2015.06.29
- 申请国别(地区):
- CN
- 年份:
- 2015
- 代理人:
- 摘要:
- 本发明公开了一种雷帕霉素与长春新碱的药物组合,包括雷帕霉素、长春新碱,其中雷帕霉素含量为0.01-1μM,长春新碱含量为10nM,或者雷帕霉素含量为1-5μM,长春新碱含量为20nM;两种剂量的雷帕霉素与长春新碱可协同杀伤、抑制包括视网膜母细胞瘤和肾母细胞瘤在内的多种儿童实体肿瘤,可作为化疗药物使用。本发明与常规用药量相比,用量少,毒性低;杀伤、抑制视网膜母细胞瘤和肾母细胞瘤的效果显著。
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
- Acyl Sulfonamides that are BCL Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated by Senescent Cells and for Treating Cancer
- Method to inhibit cancer targeting CD24
- P2X7: Inhibition of epithelial cancers and papillomas
- Phosphonamidates that are Bcl Family Antagonists for Use in Clinical Management of Conditions Caused or Mediated By Senescent Cells and for Treating Cancer